Stuart Hale Shakman – July 25 2016

©2016 S H Shakman


  This volume was originally published in an 8 x 10 format as The Autohemotherapy Reference Manual.  This second edition is being reissued in a 6 x 9 inch format as “Autoblood: The Magic Shot” (alternate title per publisher requirement).  Contents of the original publication are being fully retained as they are not otherwise available through Medline, etc.


   We are reminded of:
   - autohemotherapy’s history in a range of diseases (as documented herein);

   - its tradition as a “treatment of last resort” in otherwise hopeless cases;

   - its potential for service against AIDS, ebola, dengue fever, zika, etc.;

   - its logical use for sepsis, which by definition involves antigen in blood;

   - its role in immunotherapy vis a vis blocking metastasis of carcinoma;

   - and its no-brainer potential as a tool to be integrated into basic first aid.

   Beyond re-emphasis on the continuing value of this original publication, this “Preface to the Second Edition” highlights notable recent developments:

(1) the growth in popularity of autohemotherapy in Latin America;

(2) alternate modern “guises” of autohemotherapy;

(3) growing use of stem cells from blood rather than from bone marrow; and

(4) the continuing association of autologous methods with cancer; plus:

  --- Remembering "Autohemotherapist" Sam Tasker (1907-1999) ---


(1)  Popularity of autohemotherapy in Latin America.

Searching Google for alternate terms, the dominance of “autohemoterapia” vs “autohemotherapy” – seemingly reflects the particular interest in autoblood therapy in Latin America, e.g., Brazil, as well as in Mexico.

   Particularly well known in Brazil is the “crusading” work of Dr. Luiz Moura, who has been practicing autohemotherapy since the 1940s, taking the mantle from his father who was also a doctor. Dr. Moura and associates have been engaged in controversy with governmental and medical authorities, who have sought to outlaw the practice.  Advocates have organized with the “Campanha Nacional Em Defesa Da Auto-Hemoterapia” which seems to have been effective to date in keeping the practice available..  Dr. Moura in particular has been very active in promoting awareness of autohemotherapy through a series of videos.  See


(2)  Alternate “guises” of autohemotherapy.
  Over the years many, if not most, therapies that have involved extravascular reinjection of autologous blood or serum seemingly have not been generally categorized as “autohemotherapy” as such.  Nonetheless the same or associated underlying physiologic processes seemingly are involved.

  Some prominent modern methods that have received popular attention:

     (a) autologous (whole) blood injection (so-called ABI), alone or with “dry needling” (introduction of a fine needle), usually to treat injured tendons; and

     (b) other methods that involve centrifuging the blood, which separates out a concentrated mix of plasma, etc., which then is  injected into injured tissues in various conditions: Autologous Conditioned Plasma (ACP) for tendons; Platelet Rich Plasma (PRP) to treat “tennis elbow”; Blood-spinning, used by professional athletes in a number of sports, i.e., tennis, golf, football, soccer.

   But to date there is no indication that any of these more complex methods is preferable to ABI.  On the contrary, ABI seems to be better, or results are arguably mixed or inconclusive.  And ABI is … autohemotherapy!


(3) Therapy with stem cells from the blood rather than from bone marrow.

     The field of stem cell therapy had already become prominent as the cutting edge of medical science in the early years of the new millennium (as seen in trends within Medline & Google).

     The past decade has seen further acceleration of the replacement of bone-marrow transplantation (BMT) with stem-cell transplantation (SCT). 

     The numbers of SCT articles listed in MEDLINE between 2006 and 2016 are nearly four times greater than the number of BMT articles (60,360 versus 15,812).  This is a dramatic departure from historical trends prior to the past decade, when articles on BMT out-numbered SCT articles two to one (63,632 to 32,158).  As noted in the case of  non-Hodgkin’s Lymphoma, “marrow collections have largely been abandoned in favour of this safer and better procedure [i.e., “peripheral blood stem cell harvest”] (

  Thus stem cell therapy, which predominately uses stem cells from blood, has for the most part become a form of (concentrated) autohemotherapy.


(4) the continuing association of autologous methods with cancer.
     It is striking that the vast majority of autologous immunization methods in MEDLINE, both active and passive respectively, are involved with cancer. This is of course a grand endorsement of the use of autologous (or “personalized”) methods in the treatment of cancer.

      At the same time, the confusion over the meaning of “active” versus “passive” Immunization continues, as discussed in detail in Chapter 7, “Theoretical Considerations”.  Sir Almroth Wright had argued that “passive immunization” was actually “active immunization”, as clearly evidenced by the observation that, when effective, so-called "serum therapy" involved the application of increasing doses in a similar fashion as with “vaccine-therapy”.  To this we might well add the success in general of autologous methods against cancer, however they may be labeled.  If is autologous, by definition it comprises a self-generated vaccine against one’s own cancer, providing additional support for the Wright contention that so-called “passive immunization” is indeed a form of “active immunization”, as discussed in Chapters 1, 2 and 5.



          --- Remembering "Autohemotherapist" Sam Tasker (1907-1999) ---

      When I attempted to find a practitioner in Los Angeles in the early 1990's, I was able to make contact with a dermatologist, Sam Tasker MD.  Dr. Tasker had been using autohemotherapy in his dermatology practice for years, albeit on difficult cases.  He clearly characterized it as a “treatment of last resort” – if nothing else worked, he would try autohemotherapy.  Dr. Tasker used a method he described as "the Russian method". This was comprised of 3 cc of freshly drawn blood, with a small amount residual air in the syringe, which was then briefly shaken to more thoroughly mix the oxygen, and then nearly immediately re-injected into the muscle in the upper-arm / shoulder.  He did not change the needle in the process, using the same size needle, 25 x 5/8, for both withdrawing and re-injection. His practice was to repeat the treatment as needed bi-weekly or weekly.
     Dr. Tasker closed his practice in the 1990s and is longer with us. Fortunately Dr. Tasker had consented to a lengthy interview before his passing, available on YouTube, accessible through or (s h shakman).